June 28, 2016 at 9:00 PM EDT - Recording Available
This live session of IASLC Lung Cancer Grand Rounds features Dr. Mark Socinski. Dr. Socinski will highlight recent data in lung cancer, presented during the 2016 annual meeting of the American Society of Clinical Oncology (ASCO). The program will focus on scientific and clinical progress most likely to impact the current management of patients with lung cancer.
June 23, 2016 at 7:00PM Central European Summer Time - Recording Available
This presentation will provide an overview of the concept of angiogenesis and antiangiogenesis in NSCLC as one of the "hallmarks of cancer". Available data with bevacizumab - containing regimens in patients with advanced non squamous NSCLC - will be briefly reviewed.
Thursday May 26, 2016 6:00PM Central European Summer Time - Recording Available
This program will review radiation therapy for lung cancer highlights from the recent 2016 European Lung Cancer Conference (ELCC) and European Society for Radiotherapy & Oncology (ESTRO) meetings.
Wednesday, May 11, 2016 at 7 p.m. Central European Summer Time - Recording Available
Although patients with oncogenic-addicted NSCLC respond to targeted therapies, invariably all became refractory to the treatment as a consequence of acquired resistance. Identification of molecular mechanisms responsible for therapy failure is of crucial relevance and many new agents and strategies are currently under development.
Tuesday, April 12, 2016 at 9 p.m. Eastern Daylight Time - Recording Available
This lecture will focus on cell free DNA in lung cancer. Topics covered will include the origin and biology of cell free DNA in this disease. Analytic and clinical validity studies, as well as evidence of clinical utility in medical decision making, will also be discussed.
Thursday, March 24, 2016 - 4 p.m. Central European Time - Recording Available
The IASLC Education Committee is pleased to announce the first program in the 2016 series of Live Webinars presented by the Advanced Radiation Therapy (ART) Committee. This subcommittee is focused on the development and execution of educational and informational programs addressing state of the art radiation therapy for lung cancer. This live program will be moderated by Francoise Mornex, MD, PhD and feature presentations by Suresh Senan, MD, PhD, FRCR, and Wilko Verbakel, PhD, Ir, PEDng.
Thursday, March 10, 2016 - 7 p.m. Central European Time - Recording Available
Currently, the standard first-line treatment option for squamous cell NSCLC is cytotoxic chemotherapy (including cisplatin or carboplatin and a third-generation agent such as gemcitabine, taxanes, or vinorelbine.Targeted therapies have been tested in combination with cytotoxic chemotherapy but outcomes have been disappointing because of increased toxicity or lack of efficacy. Bevacizumab is contraindicated in patients with squamous histology tumours owing to a prohibitively high rate of severe pulmonary haemorrhage associated with bevacizumab treatment.
Wednesday, March 9, 2016 at 9 p.m. Eastern Standard Time - Recording Available
In this program, Dr. Lauren Averett Byers will discuss the current treatment of small cell lung cancer (SCLC) and review emerging therapies -- including novel targeted drugs and immunotherapies that are being investigated in clinical trials and in the lab. Recent results from clinical trials and translational studies in SCLC will be discussed, as well as representative case studies.
Friday, February 12, 2016 - 6 p.m. CET - Recording Available
The IASLC Education Committee is pleased to announce the first program in the 2016 series of Live Webinars presented by the Advanced Radiation Therapy (ART) Committee. This subcommittee is focused on the development and execution of educational and informational programs addressing state of the art radiation therapy for lung cancer. This live program will be moderated by Francoise Mornex, MD, PhD and feature presentations by Ramesh Rengan, MD, PhD and Tony Wong, PhD, DABR.